Professor Cyrus Cooper receives IOF Olof Johnell Science Award

The distinguished investigator and renowned osteoporosis advocate is honoured for his outstanding contributions to scientific research and policy implementation in the musculoskeletal field.

Cyrus Cooper, Professor of Rheumatology and Director of the MRC Lifecourse Epidemiology Unit; Vice-Dean of the Faculty of Medicine at the University of Southampton; and Professor of Epidemiology at the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, has been named the winner of the annual Olof Johnell Science Award.

The prestigious Award, granted by the International Osteoporosis Foundation (IOF) in honour of the late researcher Professor Olof Johnell, recognizes an individual who has made extraordinary and internationally recognized contributions to the field of osteoporosis in a scientific or policy implementation area.

Professor Serge Ferrari, who presented the Award today at the opening ceremony of the WCO-IOF-ESCEO 2018 in Kraków, Poland, commented:

I can think of a no more deserving recipient of this Award than Cyrus Cooper. As one the most distinguished investigators in the field, he has made numerous outstanding contributions to musculoskeletal research that have increased our knowledge about the early prevention of osteoporosis and related fractures. Through his dedicated leadership of the IOF Committee of Scientific Advisors over many years, and in his current capacity as IOF President, he has shown immense personal commitment to advancing the field on all fronts – from science and policy, to global patient advocacy.”

Cyrus Cooper leads an internationally competitive programme of research into the epidemiology of musculoskeletal disorders, most notably osteoporosis.  His key research contributions have been: 1) discovery of the developmental influences which contribute to the risk of osteoporosis and hip fracture in late adulthood; 2) demonstration that maternal vitamin D insufficiency is associated with sub-optimal bone mineral accrual in childhood; 3) characterisation of the definition and incidence rates of vertebral fractures; 4) leadership of large pragmatic randomised controlled trials of calcium and vitamin D supplementation in the elderly as immediate preventative strategies against hip fracture. 

He is President of the International Osteoporosis Foundation (IOF); Chair of the BHF Project Grants Committee; an emeritus NIHR Senior Investigator; and Associate Editor of Osteoporosis International. He has previously served as Chairman of the IOF Committee of Scientific Advisors; Chairman, MRC Population Health Sciences Research Network; and as Chairman of the National Osteoporosis Society of Great Britain. He is Past-President of the Bone Research Society of Great Britain and has worked on numerous Department of Health, European Community and World Health Organisation committees and working groups. Professor Cooper has published extensively (over 900 research papers; hi=119) on osteoporosis and rheumatic disorders and pioneered clinical studies on the developmental origins of peak bone mass. In 2015, he was awarded an OBE for services to medical research.

World Congress on Osteoporosis, Osteoarthritis & Musculoskeletal Diseases (WCO-IOF-ESCEO Kraków 2018)

Held jointly by IOF and ESCEO, the Congress takes place in Kraków, Poland, from April 19-22, 2018.
WCO-IOF-ESCEO is the world’s largest annual forum for the presentation of clinical research and new advances in the prevention and management of musculoskeletal disorders, including sarcopenia and frailty. For complete information visit   #OsteoCongress

About IOF

The International Osteoporosis Foundation (IOF) is the world's largest nongovernmental organization dedicated to the prevention, diagnosis and treatment of osteoporosis and related musculoskeletal diseases. IOF members, including committees of scientific researchers as well as 240 patient, medical and research societies in 99 locations, work together to make fracture prevention and healthy mobility a worldwide heath care priority.  @iofbonehealth


The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) is a non-profit organization, dedicated to a close interaction between clinical scientists dealing with rheumatic disorders, pharmaceutical industry developing new compounds in this field, regulators responsible for the registration of such drugs and health policy makers, to integrate the management of osteoporosis and osteoarthritis within the comprehensive perspective of health resources utilization. The objective of ESCEO is to provide practitioners with the latest clinical and economic information, allowing them to organize their daily practice, in an evidence-based medicine perspective, with a cost-conscious perception.